ClinicalTrials.Veeva

Menu

2% Chlorhexidine (CHX) vs CaOH2 (CH) Calcium Hydroxide Paste as an Intracanal Medicament

University of Southern California logo

University of Southern California

Status and phase

Not yet enrolling
Phase 3

Conditions

Apical Periodontitis

Treatments

Drug: Chlorhexidine
Drug: Calcium Hydroxide

Study type

Interventional

Funder types

Other

Identifiers

NCT03700788
HS-17-00292

Details and patient eligibility

About

This is a Pilot Phase III single-blind randomized controlled clinical trial in patients, aged 18 years and older, presenting with symptoms of apical periodontitis. The overall goal is to assess whether 2% Chlorhexidine (CHX) is superior to Calcium Hydroxide in reducing interappointment pain.

Full description

This is a Pilot Phase III single-blind randomized controlled clinical trial in patients, aged 18 years and older, presenting with symptoms of apical periodontitis. Patients will be treated with one of two current clinically-used medications, 2% chlorohexidine (intervention) vs. calcium hydroxide (standard-of-care). One week following treatment (+/- 2 days), patients will return for reevaltuion of apical periodontitis symptoms, via patient's pain perception after a bite test.

The primary objective of the proposed study is to determine if there is a difference in 7-day (+/- 2) post-procedure apical periodontitis following randomization to either 2% chlorohexidine vs. calcium hydroxide paste among patients presenting with symptoms of apical periodontitis. Additionally, the investigators will assess the number of adverse events that occur in each treatment group to determine if there appears to be a difference across groups, descriptively.

Enrollment

40 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • 18 years and older
  • symptomatic apical periodontitis (positive to the bite test)
  • restorable tooth
  • requires root canal therapy
  • able to undergo informed consent process
  • must be English or Spanish speaker

Exclusion criteria

  • Cracked tooth
  • non-restorable tooth
  • no pain medication or antibiotic taken in the past 3 days

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

40 participants in 2 patient groups

Clorhexidine
Experimental group
Description:
2% Chlorhexidine
Treatment:
Drug: Chlorhexidine
Calcium Hydroxide
Active Comparator group
Description:
Calcium Hydroxide
Treatment:
Drug: Calcium Hydroxide

Trial contacts and locations

1

Loading...

Central trial contact

C L Fath, D.D.S.; Ramon Roges, D.D.S.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems